Aug 2026
High Cancer Inflammation Prognostic Index Identifies Patients With Stage II Colorectal Cancer With Outcomes Comparable to Stage III
CIPI identifies biologically high-risk stage II CRC with long-term outcomes comparable to stage III disease among patients with normal CA19-9 levels, supporting its role as a complementary prognostic tool beyond conventional pathological staging.
Teppei Kamada, Yasuhiro Takano, Keisuke Goto et al.
· Anticancer Research · 0 citations